Oral Idasanutlin in Patients with Polycythemia Vera.
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood.2018893545
Abstract: A limited number of drugs are available to treat patients with polycythemia vera (PV) and essential thrombocythemia (ET). We attempted to identify alternative agents that may target abnormalities within malignant hematopoietic stem and progenitor cells… read more here.
Keywords: oral idasanutlin; polycythemia vera; idasanutlin patients; patients polycythemia ... See more keywords
Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.01156
Abstract: The spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), firstly detected in Wuhan (China) at the end of 2019, has rapidly reached pandemic status. At the present time, under the “pressure” of… read more here.
Keywords: covid patients; oral idasanutlin; covid; considering oral ... See more keywords